Results 201 to 210 of about 381,163 (319)

Apolipoprotein B - An ideal biomarker for atherosclerosis? [PDF]

Indian Heart J
Singh K, Prabhakaran D.
europepmc   +1 more source

Lipoprotein(a) and risk-weighted apolipoprotein B: a novel metric for atherogenic risk. [PDF]

Lipids Health Dis
Rehman MB, Tudrej BV.
europepmc   +1 more source

The association of apolipoprotein B with chronic kidney disease in the Chinese population. [PDF]

Front Endocrinol (Lausanne), 2023
Xu Y, Liu B, Lin L, Lei F, Sun T, Zhang X, Song X, Huang X, Zeng Q, Cai J, Wang Z, Li H.   +11 more
europepmc   +1 more source

Apolipoprotein A‐V Regulation of Apolipoprotein B Secretion

The FASEB Journal, 2006
Robert O. Ryan, Trudy M. Forte, Xiao Shu
openaire   +1 more source

Lipoprotein B37, a naturally occurring lipoprotein containing the amino-terminal portion of apolipoprotein B100, does not bind to the apolipoprotein B,E (low density lipoprotein) receptor.

, 1987
Stephen G. Young, FP Peralta, BW Dubois, LK Curtiss, JK Boyles, JL Witztum   +5 more
openalex   +1 more source

Per‐ and polyfluoroalkyl substances activate UPR pathway, induce steatosis and fibrosis in liver cells

Environmental Toxicology, Volume 38, Issue 1, Page 225-242, January 2023., 2023
Abstract Per‐ and polyfluoroalkyl substances (PFAS), which include perfluorooctanoic acid (PFOA), heptafluorobutyric acid (HFBA), and perfluorotetradecanoic acid (PFTA), are commonly occurring organic pollutants. Exposure to PFAS affects the immune system, thyroid and kidney function, lipid metabolism, and insulin signaling and is also involved in the ...
Qi Qi, Suryakant Niture, Sashi Gadi, Elena Arthur, John Moore, Keith E. Levine, Deepak Kumar   +6 more
wiley   +1 more source

Apolipoprotein B-48 and late graft failure in kidney transplant recipients. [PDF]

Clin Kidney J
Szili-Torok T, de Borst MH, Soteriou A, Post L, Bakker SJL, Tietge UJF.   +5 more
europepmc   +1 more source

1155 NORMOTRIGLYCERIDEMIC ABETALIPOPROTEINEMIA: FATE OF APOLIPOPROTEIN B OF CHYLOMICRONS [PDF]

, 1981
Mary J. Malloy, John P. Kane, Carolyn P Piel   +2 more
openalex   +1 more source

Low prevalence of testing for apolipoprotein B and lipoprotein (a) in the real world. [PDF]

Am J Prev Cardiol
Murdock DJ, Moll K, Sanchez RJ, Gu J, Fazio S, Geba GP, Rodriguez F.   +6 more
europepmc   +1 more source

Apolipoprotein B (B-46)

Biomedicine & Pharmacotherapy, 1990
openaire   +2 more sources